S 1132
117th Congress
Senate
Health
Child health
Digestive and metabolic diseases
Employee benefits and pensions
Health care costs and insurance
Health care coverage and access
Health technology, devices, supplies
Inflation and prices
Medicaid
Medicare
Military medicine
Military personnel and dependents
Poverty and welfare assistance
Prescription drugs
Veterans' medical care
EPI Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 15, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 15, 2021
Introduced in Senate
Plain-English summary
Ending Pricey Insulin Act or the EPI Act
This bill establishes a maximum out-of-pocket cost of $50 for a 30-day supply of insulin.
Specifically, no private or public health insurance plan may charge an enrollee more than $50 for a 30-day supply of insulin, regardless of the amount of insulin prescribed for that period. This includes any deductible, co-payment, coinsurance, or other cost-sharing requirement.
This $50 limit also applies to the cash price for insulin prescriptions for uninsured individuals.
The requirements of this bill apply beginning on January 1, 2022, irrespective of the date this bill is enacted.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1